Multiple Dose, Steady State-Partial reference replicate [Design Issues]

posted by ElMaestro  – Denmark, 2018-07-13 13:42 (1071 d 15:48 ago) – Posting: # 19047
Views: 3,119

Hi arl_stat,

» Please help in understanding whether it is possible to conduct “An open-label, randomized, Multiple Dose, Steady State, two treatments, three periods, three sequence, three way, Reference Replicated crossover bioequivalence study” for USFDA Submission?

Yes to everything except (conditionally) the term 'three way' in the context of your post.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,529 posts in 4,499 threads, 1,523 registered users;
online 23 (0 registered, 23 guests [including 3 identified bots]).
Forum time: Saturday 05:31 CEST (Europe/Vienna)

Anyone who has never made a mistake
has never tried anything new.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5